Status:
COMPLETED
Basal Tumours in Bladder Cancer, Response to chemoTherapy
Lead Sponsor:
University Hospital, Rouen
Collaborating Sponsors:
Institut Curie
APHP
Conditions:
Bladder Cancer
Chemotherapy Effect
Eligibility:
All Genders
18-80 years
Brief Summary
Determine the sensitivity/resistance to chemotherapy of the various subgroups of muscle-invasive bladder cancers, including the basal subgroup (about 25% of these tumours) according to 4 different cla...
Eligibility Criteria
Inclusion
- Inclusion Criteria of Patients enrolled in VESPER study:
- Tumors from patient having muscle invasive bladder cancer who benefit from neoadjuvant chemotherapy with cisplatine included in VESPER cohort and :
- having signed an informed consent form for the participation to the collection or
- dead/lost to follow-up without prior opposition expressed against research program,
- genetic analysis will only be carried out for patients who have signed the genetic consent form.
- Inclusion Criteria of Patients from St Louis cohort not enrolled in VESPER study:
- Tumors from patient having muscle invasive bladder cancer who benefit from neoadjuvant chemotherapy with cisplatine included in Saint-Louis cohort and :
- having received an informed form for the participation to the collection and not having expressed opposition against research program within 1 month or
- dead/lost to follow-up without prior opposition expressed against research program,
- Exclusion Criteria:
- Patients enrolled in VESPER study:Tumors from patient having withdrawn his/her informed consent form for the participation to the collection and/or VESPER project.
- OR
- Patients from St Louis not enrolled in VESPER study:Tumors from patient having expressed opposition against research program after 1 month for the participation to the collection.
Exclusion
Key Trial Info
Start Date :
February 27 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 29 2019
Estimated Enrollment :
293 Patients enrolled
Trial Details
Trial ID
NCT04089748
Start Date
February 27 2019
End Date
April 29 2019
Last Update
June 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DRCI
Rouen, France, 76000